Advances in the generation of mouse models to elucidate the pathways of drug metabolism in rodents and man

References

• Xia CQ, Milton MN, Gan LS. Evaluation of drug-transporter interactions using in vitro and in vivo models. Curr. Drug Metab.8(4), 341–363 (2007).
   PubMed Web of Science ®Google Scholar
• Mizuno N, Niwa T, Yotsumoto Y, Sugiyama Y. Impact of drug transporter studies on drug discovery and development. Pharmacol. Rev.55(3), 425–461 (2003).
   PubMed Web of Science ®Google Scholar
• Constan AA, Sprankle CS, Peters JM et al. Metabolism of chloroform by cytochrome P450 2E1 is required for induction of toxicity in the liver, kidney, and nose of male mice. Toxicol. Appl. Pharmacol.160(2), 120–126 (1999).
   PubMed Web of Science ®Google Scholar
• Lee SS, Buters JT, Pineau T, Fernandez-Salguero P, Gonzalez FJ. Role of CYP2E1 in the hepatotoxicity of acetaminophen. J. Biol. Chem.271(20), 12063–12067 (1996).
   PubMed Web of Science ®Google Scholar
• Wong FW, Chan WY, Lee SS. Resistance to carbon tetrachloride-induced hepatotoxicity in mice which lack CYP2E1 expression. Toxicol. Appl. Pharmacol.153, 109–118 (1998).
   PubMed Web of Science ®Google Scholar
• Wei P, Zhang J, Egan-Hafley M, Liang S, Moore DD. The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature407(6806), 920–923 (2000).
   PubMed Web of Science ®Google Scholar
• Henderson CJ, Otto DM, McLaren AW, Carrie D, Wolf CR. Knockout mice in xenobiotic metabolism. Drug Metab. Rev.35(4), 385–392 (2003).
   PubMed Web of Science ®Google Scholar
• Henderson CJ, Wolf CR. Transgenic analysis of human drug-metabolizing enzymes: preclinical drug development and toxicology. Mol. Interventions3(6), 331–343 (2003).
   PubMedGoogle Scholar
• Otto DM, Henderson CJ, Carrie D et al. Identification of novel roles of the cytochrome P450 system in early embryogenesis: effects on vasculogenesis and retinoic acid homeostasis. Mol. Cell Biol.23(17), 6103–6116 (2003).
   PubMed Web of Science ®Google Scholar
• Shen AL, O’Leary KA, Kasper CB. Association of multiple developmental defects and embryonic lethality with loss of microsomal NADPH-cytochrome P450 oxidoreductase. J. Biol. Chem.277(8), 6536–6541 (2002).
   PubMed Web of Science ®Google Scholar
• Gu J, Weng Y, Zhang QY et al. Liver-specific deletion of the NADPH-cytochrome P450 reductase gene: impact on plasma cholesterol homeostasis and the function and regulation of microsomal cytochrome P450 and heme oxygenase. J. Biol. Chem.278(28), 25895–25901 (2003).
   PubMed Web of Science ®Google Scholar
• Henderson CJ, Otto DM, Carrie D et al. Inactivation of the hepatic cytochrome P450 system by conditional deletion of hepatic cytochrome P450 reductase. J. Biol. Chem.278(15), 13480–13486 (2003).
   PubMed Web of Science ®Google Scholar
• Gu J, Chen CS, Wei Y et al. A mouse model with liver-specific deletion and global suppression of the NADPH-cytochrome P450 reductase gene: characterization and utility for in vivo studies of cyclophosphamide disposition. J. Pharmacol. Exp. Ther.321(1), 9–17 (2007).
   PubMed Web of Science ®Google Scholar
• Pass GJ, Carrie D, Boylan M et al. Role of hepatic cytochrome p450s in the pharmacokinetics and toxicity of cyclophosphamide: studies with the hepatic cytochrome p450 reductase null mouse. Cancer Res.65(10), 4211–4217 (2005).
   PubMed Web of Science ®Google Scholar
• Finn RD, McLaughlin LA, Ronseaux S et al. Defining the in vivo role for cytochrome b5 in cytochrome P450 function through the conditional hepatic deletion of microsomal cytochrome b5. J. Biol. Chem.283(46), 31385–31393 (2008).
   PubMed Web of Science ®Google Scholar
• Herold MJ, van den Brandt J, Seibler J, Reichardt HM. Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats. Proc. Natl Acad. Sci. USA105(47), 18507–18512 (2008).
   PubMed Web of Science ®Google Scholar
• Cheung C, Gonzalez FJ. Humanized mouse lines and their application for prediction of human drug metabolism and toxicological risk assessment. J. Pharmacol. Exp. Ther.327(2), 288–299 (2008).
   PubMed Web of Science ®Google Scholar
• Ma X, Shah Y, Cheung C et al. The PREgnane X receptor gene-humanized mouse: a model for investigating drug–drug interactions mediated by cytochromes P450 3A. Drug Metab. Dispos.35(2), 194–200 (2007).
   PubMed Web of Science ®Google Scholar
• Scheer N, Ross J, Rode A et al. A novel panel of mouse models to evaluate the role of human pregnane X receptor and constitutive androstane receptor in drug response. J. Clin. Invest.118(9), 3228–3239 (2008).
   PubMed Web of Science ®Google Scholar
• Cheung C, Akiyama TE, Ward JM et al. Diminished hepatocellular proliferation in mice humanized for the nuclear receptor peroxisome proliferator-activated receptor α. Cancer Res.64(11), 3849–3854 (2004).
   PubMed Web of Science ®Google Scholar
• Yang Q, Nagano T, Shah Y, Cheung C, Ito S, Gonzalez FJ. The PPAR α-humanized mouse: a model to investigate species differences in liver toxicity mediated by PPAR α. Toxicol. Sci.101(1), 132–139 (2008).
   PubMed Web of Science ®Google Scholar
• Moriguchi T, Motohashi H, Hosoya T et al. Distinct response to dioxin in an arylhydrocarbon receptor (AHR)-humanized mouse. Proc. Natl Acad. Sci. USA100(10), 5652–5657 (2003).
   PubMed Web of Science ®Google Scholar
• Gonzalez FJ, Yu AM. Cytochrome P450 and xenobiotic receptor humanized mice. Ann. Rev. Pharmacol. Toxicol.46, 41–64 (2006).
   PubMed Web of Science ®Google Scholar
• Corchero J, Granvil CP, Akiyama TE et al. The CYP2D6 humanized mouse: effect of the human CYP2D6 transgene and HNF4α on the disposition of debrisoquine in the mouse. Mol. Pharmacol.60(6), 1260–1267 (2001).
   PubMed Web of Science ®Google Scholar
• Granvil CP, Yu AM, Elizondo G et al. Expression of the human CYP3A4 gene in the small intestine of transgenic mice: in vitro metabolism and pharmacokinetics of midazolam. Drug Metab. Dispos.31(5), 548–558 (2003).
   PubMed Web of Science ®Google Scholar
• Dragin N, Uno S, Wang B, Dalton TP, Nebert DW. Generation of ‘humanized’ hCYP1A1_1A2_Cyp1a1/1a2-/- mouse line. Biochem. Biophys. Res. Commun.359(3), 635–642 (2007).
   PubMed Web of Science ®Google Scholar
• van Herwaarden AE, Wagenaar E, van der Kruijssen CM et al. Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism. J. Clin. Invest.117(11), 3583–3592 (2007).
   PubMed Web of Science ®Google Scholar
• van Waterschoot RA, van Herwaarden AE, Lagas JS et al. Midazolam metabolism in Cytochrome P450 3A knockout mice can be attributed to upregulated CYP2C enzymes. Mol. Pharmacol.73(3), 1029–1036 (2008).
   PubMed Web of Science ®Google Scholar
• Chen S, Beaton D, Nguyen N et al. Tissue-specific, inducible, and hormonal control of the human UDP-glucuronosyltransferase-1 (UGT1) locus. J. Biol. Chem.280(45), 37547–37557 (2005).
   PubMed Web of Science ®Google Scholar
• Azuma H, Paulk N, Ranade A et al. Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice. Nat. Biotechnol.25(8), 903–910 (2007).
   PubMed Web of Science ®Google Scholar
• Tateno C, Yoshizane Y, Saito N et al. Near completely humanized liver in mice shows human-type metabolic responses to drugs. Am. J. Pathol.165(3), 901–912 (2004).
   PubMed Web of Science ®Google Scholar
• Katoh M, Yokoi T. Application of chimeric mice with humanized liver for predictive ADME. Drug Metab. Rev.39(1), 145–157 (2007).
   PubMed Web of Science ®Google Scholar
• Campbell SJ, Carlotti F, Hall PA, Clark AJ, Wolf CR. Regulation of the CYP1A1 promoter in transgenic mice: an exquisitely sensitive on–off system for cell specific gene regulation. J. Cell. Sci.109(11), 2619–2625 (1996).
   PubMed Web of Science ®Google Scholar
• Campbell SJ, Henderson CJ, Anthony DC, Davidson D, Clark AJ, Wolf CR. The murine Cyp1a1 gene is expressed in a restricted spatial and temporal pattern during embryonic development. J. Biol. Chem.280(7), 5828–5835 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang W, Purchio AF, Chen K et al. A transgenic mouse model with a luciferase reporter for studying in vivo transcriptional regulation of the human CYP3A4 gene. Drug Metab. Dispos.31(8), 1054–1064 (2003).
   PubMed Web of Science ®Google Scholar
• Stedman C, Robertson G, Coulter S, Liddle C. Feed-forward regulation of bile acid detoxification by CYP3A4: studies in humanized transgenic mice. J. Biol. Chem.279(12), 11336–11343 (2004).
   PubMed Web of Science ®Google Scholar
• Zhang W, Moorthy B, Chen M et al. A Cyp1a2-luciferase transgenic CD-1 mouse model: responses to aryl hydrocarbons similar to the humanized AhR mice. Toxicol. Sci.82(1), 297–307 (2004).
   PubMed Web of Science ®Google Scholar